Remission of human type 2 diabetes requires decrease in liver and pancreas fat content but is dependent upon capacity for cell recovery
The choice between the two medications should involve a thorough evaluation by a healthcare provider, considering factors like your overall health, specific weight loss goals, medication tolerance, and any underlying medical conditions
Same rules, same temperatures, same emphasis on minimizing exposure
For the primary analysis, a Cox proportional hazards model was used to test for non-inferiority of OZEMPIC to placebo for time to first MACE using a risk margin of 1.3
The two most popular types of GLP-1 receptor agonists are semaglutides, such as Ozempic and Wegovy, and tirzepatides, such as Mounjaro and Zepbound
Semaglutide, a GLP-1 receptor agonist approved by the FDA for type 2 diabetes and chronic weight management, has important effects on liver enzymes that clinicians and patients should understand